Skip to main content

Polyelectrolyte Fractionation Technology

  • Chapter

Part of the book series: Developments in Hematology and Immunology ((DIHI,volume 13))

Abstract

A series of solid phase polyelectrolytes based on ethylene maleic anhydride co-polymer have been used to develop a flexible integrated system for the fractionation of plasma (1).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Johnson A J, MacDonald VE, Semar M, et al. Preparation of the major plasma fractions by solid phase polyelectrolytes. J Lab Clin Med. 1976;922:194–210.

    Google Scholar 

  2. Galpin SA, Karayiannis P, Middleton SM, Thomas HC, The removal of Hepatitis B Virus from factor VIII concentrates by fractionation on Ethylene Maleic Anhydride Polyelectrolyte J. of Med. Virol. In Press.

    Google Scholar 

  3. Tuddenham EGD, Lane RS, Rotblat F et al. Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human Haemophilia A and Von Willebrands disease. Brit J Haemat 1982;52:259–67.

    Article  PubMed  CAS  Google Scholar 

  4. Rotblat F, O’Brien DP, Middleton SM, Tuddenham EGD. Purification and characterisation of human factor VIII:C. Thromb. Haemost. 1983;50:108.

    Google Scholar 

  5. Macfarlane RG, Mallam PC, Wills LJ et al. Surgery in haemophilia — The use of animal antihaemophilic globulin and human plasma in thirteen cases. Lancet 1957;ii:251.

    Article  Google Scholar 

  6. Forbes CD, Prentice CMR. Aggregation of human platelets by purified porcine and bovine antihaemophilic factor. Nature New Biol. 1973;241:149.

    Article  PubMed  CAS  Google Scholar 

  7. Kernoff PBA, Thomas ND, Lilley PA et al. Clinical experience with polyelectrolyte fractionated porcine factor VIII concentrate in the treatment of Haemophiliacs with antibodies to factor VIII. Blood 1984;63:31–41.

    PubMed  CAS  Google Scholar 

  8. Gatti L, Mannucci P. Use of porcine factor VIII in the management of seventeen patients with factor VIII antibodies. Thromb. Haemost. 1984;51:379–84.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Martinus Nijhoff Publishing, Boston

About this chapter

Cite this chapter

Middleton, S.M. (1985). Polyelectrolyte Fractionation Technology. In: Smit Sibinga, C.T., Das, P.C., Seidl, S. (eds) Plasma Fractionation and Blood Transfusion. Developments in Hematology and Immunology, vol 13. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2631-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2631-1_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9644-7

  • Online ISBN: 978-1-4613-2631-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics